Paramount Skydance agreed to a longer-term delay of its $111 billion acquisition of Warner Bros. Discovery, preventing the companies from combining until after a judge rules on the merits of a case in which a dozen states challenged the legality of the merger.

Under a stipulation filed in court today, the states and companies agreed that the merger will not be completed and the firms will not integrate their operations until "five days after the merits determination in these matters," or on June 1, 2027, whichever is earlier. The delay was also agreed to by the Writers Guild of America, which filed its own lawsuit to block the merger. If there is no merits determination by June 1, the plaintiffs could seek a preliminary injunction to keep blocking the deal.

The agreement amounts to "a months-long halt" to the merger, New York Attorney General Letitia James' office said. “Halting this merger while our case proceeds is a critical victory in our efforts to uphold the law and protect the film and television industries," James said.

Read full article

Comments

© Getty Images | NurPhoto

The court blocked the companies from closing the acquisition through mid-August, as a judge considers two lawsuits challenging it.

A ring in Quebec’s wilderness turned out to be a rare cosmic scar.

In an era where depression remains one of the most pervasive mental health disorders worldwide, emerging research continues to unravel the complex interactions within our bodies that may offer new treatment avenues. A groundbreaking study recently published in Translational Psychiatry has illuminated a remarkable connection between the vagus nerve, gut microbiota, and the antidepressant effects of a novel compound called ineupatorolide B. This discovery not only broadens the scientific understanding of depression but also signals new directions for therapeutic interventions targeting the gut-brain axis.

Depression’s multifaceted nature has long challenged researchers and clinicians alike. Traditionally, treatments have focused on modulating neurotransmitters in the brain, such as serotonin and dopamine. However, increasing evidence reveals that the gut-brain axis — a bidirectional communication pathway linking the central nervous system and the gastrointestinal tract — plays a critical role in regulating mood and behavior. The vagus nerve acts as a central highway in this communication chain, transmitting signals between the gut microbiota and the brain. New data suggests that manipulating this neural conduit might be key to unlocking novel antidepressant mechanisms.

At the core of the study by Wang and colleagues lies ineupatorolide B, a bioactive compound isolated from natural sources with previously unexplored neuropsychiatric potential. Using a well-validated mouse model of depression, the researchers meticulously demonstrated that administration of ineupatorolide B amends depressive-like behaviors, an effect intricately linked to alterations in the gut microbial community. The compound’s antidepressant actions were shown to be dependent on an intact vagus nerve, underscoring the impossibility of fully dissociating gut-brain interactions from mood regulation.

To induce depressive symptoms in mice, the team employed chronic stress paradigms mimicking real-world psychological stressors. Behavioral assessments post-treatment revealed notable improvements in exploratory behavior and reduced signs of despair, pointing to the efficacy of ineupatorolide B. Subsequent gut microbiota analyses uncovered a significant shift in microbial diversity and composition following treatment, characterized by an enrichment of beneficial bacterial taxa previously associated with anti-inflammatory and neuroprotective functions.

The vagus nerve, often described as the “information superhighway” of the parasympathetic nervous system, emerged as the linchpin in this neuro-gastrointestinal axis. When the researchers surgically severed or pharmacologically inhibited the vagus nerve, the antidepressant benefits of ineupatorolide B were abolished. This pivotal finding confirms that gut microbiota alterations alone are insufficient and must be coupled with vagus-mediated signaling to exert mood-enhancing effects, highlighting a complex neuroimmune dialogue.

Delving deeper, molecular and immunohistochemical analyses revealed that ineupatorolide B impacts systemic and neural inflammatory pathways. The compound reduced expression of pro-inflammatory cytokines within the hippocampus, a brain region critically implicated in mood disorders, while simultaneously fostering neurogenesis and synaptic plasticity. These neurobiological enhancements offer plausible mechanistic explanations for the behavioral improvements observed and reinforce the notion that inflammation is intricately tied to depression’s pathophysiology.

Perhaps most intriguingly, the study unveiled a specific pattern of microbial metabolites altered by ineupatorolide B treatment. These metabolites are hypothesized to cross the gut-blood barrier and act on vagal afferent fibers, modulating neuronal excitability and neurotransmitter release. Such findings cultivate an emerging paradigm where microbial metabolites are not mere byproducts but active signaling molecules intricately shaping the neurochemical milieu of the brain.

The implications of these findings ripple far beyond basic science. In clinical settings, harnessing vagus-dependent pathways could revolutionize antidepressant therapies by focusing on microbiota modulation rather than conventional neurotransmitter-targeted drugs, many of which suffer from delayed onset and limited efficacy. This research provides a compelling preclinical rationale for developing compounds that modulate gut-brain interactions more precisely and with fewer adverse effects.

Moreover, the identification of ineupatorolide B as a bioactive agent extends the possibilities of phytochemical and natural product libraries as untapped reservoirs for neuropsychiatric drug discovery. While still in early stages, translational efforts can now investigate whether such compounds, alone or in synergy with probiotic treatments, can elicit robust therapeutic outcomes in humans suffering from depression and related disorders.

Future inquiries will need to delineate the precise molecular receptors on vagal afferents activated by microbial metabolites induced by ineupatorolide B, a vital step toward targeted drug design. Additionally, unraveling the longitudinal effects and safety profiles of modulating the gut-brain axis via this compound will be essential in moving toward clinical applications.

Beyond depression, these insights may have broader implications for other neuropsychiatric and neurodegenerative diseases also characterized by gut dysbiosis and neuroinflammation, such as anxiety, Parkinson’s disease, and multiple sclerosis. As the field of psychobiotics burgeons, the vagus nerve stands out as a promising therapeutic target whose modulation could recalibrate the neural circuits governing emotion, cognition, and behavior.

The integration of microbiology, neurobiology, and pharmacology showcased in this study epitomizes the power of interdisciplinary science to unlock novel therapeutic pathways. Wang and colleagues’ work thus represents a beacon in personalized medicine strategies aimed at mental health, a field urgently craving innovation as global depression rates continue to climb amid societal challenges.

In summary, the discovery that ineupatorolide B’s antidepressant efficacy is mediated by vagus nerve-dependent modulation of gut microbiota ushers in a transformative perspective on depression treatment. By bridging peripheral microbial ecosystems with central nervous system function via neural pathways, this research redefines our understanding of depression’s origins and therapeutic targets, inspiring the next generation of holistic and targeted interventions for mental health.

As the scientific community rallies around the gut-brain axis, studies such as this underscore the necessity of viewing depression through a systemic lens, acknowledging the profound interplay between the body and mind. This conceptual shift stands poised to not only improve treatment outcomes but also destigmatize mental illness by emphasizing its biological complexity.

Ultimately, as neuroscience continues to unravel the enigmatic connections between microbiota, neural circuits, and behavior, hopes rise for innovative treatments grounded in nature’s own chemical repertoire. Ineupatorolide B shines as a fascinating candidate at this frontier, exemplifying the promise held by gut-mediated neuromodulation in conquering depression’s global burden.

---

Subject of Research:
Vagus nerve-mediated antidepressant effects of ineupatorolide B through modulation of gut microbiota in a mouse depression model.

Article Title:
Vagus nerve–dependent antidepressant effects of ineupatorolide B via gut microbiota modulation in a mouse model of depression.

Article References:
Wang, S., Zhang, Y., Wu, N. et al. Vagus nerve–dependent antidepressant effects of ineupatorolide B via gut microbiota modulation in a mouse model of depression. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04127-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04127-x

The pharmaceutical industry has spent years investing in machine learning, predictive analytics, and computational biology. Yet many research

In a groundbreaking series of experiments conducted by researchers at the University of Jena, scientists have revisited and expanded upon a century-old discovery that shapes our understanding of embryonic development. Originally unearthed by Hans Spemann and his student Hilde Mangold in 1924, the concept of the “organiser” is a pivotal developmental mechanism that directs the formation of body axes during the early stages of an embryo’s growth. Spemann and Mangold’s pioneering work involved tissue transplantation between amphibian embryos, revealing the presence of a group of cells within the blastopore that orchestrate the development of a secondary body axis. This discovery earned Spemann a Nobel Prize in 1935 but tragically Mangold passed away young, never witnessing the lasting impact of their findings.

The new research from Jena not only reaffirms these foundational insights but extends them dramatically into the early evolutionary origins of metazoans. Using delicate microsurgical manipulation, the team studied the ribbed comb jelly Mnemiopsis leidyi, a member of the ancient phylum Ctenophora. This lineage diverged from that of other animals approximately 700 million years ago, according to the latest evolutionary models. By transplanting small portions of blastoporal tissue from one comb jelly embryo into another, Jena researchers induced a secondary body axis, effectively recapitulating Spemann and Mangold’s classic findings but now in one of the earliest-diverging animal lineages. The experiment demonstrated that the organiser’s developmental blueprint is deeply conserved across vast evolutionary time frames.

What makes these experiments particularly astounding is the technical difficulty involved. Comb jelly embryos measure only about 120 micrometers in diameter—just a fraction larger than the width of a human hair—while the transplanted tissue samples were barely 20 micrometers in size. Dr. Stanislav Kremnyov, the lead experimentalist, had to master an extraordinary level of manual dexterity to integrate these tiny groups of cells into host embryos without triggering rejection or other developmental derailments. To an outside observer, it appeared as if the researchers were “dissecting clouds,” a vivid metaphor used by Prof. Andreas Hejnol, who leads the research team at Jena.

The functional transplantation of organising tissue between individuals of the same species was spectacular enough. Yet the Jena team dared to push further by performing xenotransplantations, transferring organiser tissue across animal orders into the sea anemone, a cnidarian species that diverged from ctenophores roughly 60 million years later. Remarkably, the transplanted organiser tissue also initiated axis formation in the sea anemone embryos. This unprecedented success underscores the extraordinary evolutionary conservation of developmental mechanisms underpinning animal body plans. Xenotransplantation of organiser tissues across distinct phyla had never before been demonstrated, marking this as a historic advance in developmental biology.

Beyond the cellular choreography, the study also zeroed in on genetic underpinnings. The team identified, for the first time, the specific gene responsible for organiser formation in the sea anemone, bridging molecular mechanisms across species boundaries. This gene appears to regulate the signalling networks critical to early embryonic axis determination, providing a molecular anchor to the organiser’s functional role. Such findings hint that the genetic toolkit necessary for complex body plan organisation was already present in the earliest multicellular ancestors of modern animals.

These discoveries overturn previous assumptions that organiser-driven axis formation was a feature exclusive to more recently evolved animal groups such as bilaterians. Instead, the findings position the organiser as a primordial control system in multicellular organism development, dating back to the dawn of animal evolution itself. It suggests a remarkable evolutionary continuity where the fundamental blueprints for constructing the three-dimensional architecture of multicellular animals remained largely stable across hundreds of millions of years.

The implications of this research extend far beyond ctenophores and sea anemones. Since the organiser guides the spatial coordination of cell fate during development, understanding its origins and conservation sheds light on the evolutionary emergence of animal diversity and complexity. It also offers potential new perspectives for biomedical research, particularly in regenerative medicine and congenital defect studies, where guiding axis formation and tissue patterning is critical.

Technical mastery was central to these findings. The researchers employed advanced microscopy and vital cell staining techniques allowing them to trace transplanted cells dynamically within host embryos. Coupling this with precise microsurgical transplantation provided not only functional but also visual confirmation of organiser activity. This combination of cutting-edge experimental methods enabled insights previously thought unattainable in such fragile and inaccessible embryonic systems.

Prof. Andreas Hejnol reflects on the evolutionary significance with enthusiasm: “Our data demonstrate that this organizer mechanism coordinates the entire body axis and is conserved among one of the earliest-diverging animal lineages, suggesting that complex body plan organisation arose very early in metazoan evolution.” His team’s work bridges developmental biology with evolutionary biology, providing a vivid example of how ancient developmental principles underpin the incredible diversity of life forms on Earth today.

This research, published in the prestigious journal Nature, represents a milestone in understanding early animal evolution and embryogenesis. It dramatically shifts the paradigm surrounding the origins of the organiser and prompts reconsideration of the molecular and cellular processes foundational to animal multicellularity. As scientists continue to explore these ancient mechanisms, further revelations about the building blocks of life’s complexity are eagerly anticipated.

Subject of Research: Animals
Article Title: A blastoporal organiser in a ctenophore
News Publication Date: 17-Jun-2026
Web References: http://dx.doi.org/10.1038/s41586-026-10643-z
Image Credits: Lisa-Marie Barf
Keywords: embryonic development, organiser, blastopore, ctenophore, Mnemiopsis leidyi, evolutionary biology, axis formation, multicellularity, xenotransplantation, sea anemone, cnidaria, developmental genetics

A groundbreaking discovery has emerged from the subtropical mangrove wetlands of Hengqin Island, Guangdong Province, where a team of researchers from Sun Yat-sen University, in collaboration with other institutions, has identified a new species of bumblebee goby, Brachygobius jennie. This finding not only extends the known geographical distribution of the genus Brachygobius northeastward but also documents the first recorded presence of this group of small, estuarine fishes in China. The discovery was published in the prestigious journal Zoosystematics and Evolution, shedding light on a species that challenges conventional understanding of biodiversity in well-studied regions.

During routine fieldwork in the Zhujiang River Estuary wetlands, Jiangyan Tian, a postgraduate student at SYSU, was captivated by the presence of diminutive fishes inhabiting shallow waters near the substrate. Initially mistaken for juveniles of known species, these tiny organisms intrigued Tian due to their distinctive body markings, which deviated from any documented regional fish species. This unexpected observation prompted a deep dive into integrative taxonomic methods that combined morphological examination with genetic analyses, facilitated by her supervisor Jianrong Huang and colleagues Chunliu Lan and Jianyong Wu.

The integration of genetic sequencing and morphological diagnostics was pivotal in delineating Brachygobius jennie as a novel species. The comprehensive study leveraged molecular phylogenetics to affirm the genetic distinctiveness of the new goby relative to its congeners. Morphologically, B. jennie displays a unique pattern of four narrow body bars located behind the head, a trait not observed in related species. Notably, the presence of a chevron-shaped second bar that extends fully to the midventral line provides a striking visual marker distinguishing this species, alongside two additional bars positioned posterior to the anal fin base.

This species’ extraordinary small stature sets it apart within its genus and the broader ichthyofauna of China. Reaching a maximum standard length of under nine millimeters, Brachygobius jennie may be the smallest fish species known in China, and among the tiniest vertebrates worldwide. Such extreme miniaturization necessitates profound anatomical and physiological adaptations, which remain fertile ground for future biological investigation. These evolutionary modifications induced by size constraints offer critical insight into developmental biology and ecological specialization within aquatic vertebrates.

Co-author Sébastien Lavoué from Universiti Sains Malaysia expressed enthusiasm for the collaboration, highlighting the novelty and distinctiveness of Brachygobius jennie. His involvement underscores the international scientific interest in this diminutive and unique goby, bridging expertise across countries and disciplines. The interdisciplinary approach adopted by the research team exemplifies modern taxonomy’s reliance on cross-border cooperation and advanced methodologies, crucial for uncovering concealed biodiversity even in well-explored ecosystems.

The nomenclature of this newly described species holds particular cultural significance. The fish is named in honor of Jennie Ruby Jane, a prominent South Korean singer, whose music served as a beacon of inspiration for Jiangyan Tian during the demanding phases of the research. This homage illustrates the interplay between science and personal experience, enriching the narrative of scientific discovery by acknowledging influences beyond the laboratory or field site.

Brachygobius jennie inhabits estuarine environments characterized by subtropical mangrove wetlands, a habitat typified by dynamic salinity gradients, rich organic substrates, and ecological complexity. These environments are increasingly under anthropogenic threat from urbanization, pollution, and climate change, putting endemic and specialized species at risk. The identification of B. jennie brings attention to the biodiversity value of estuarine ecosystems in Asia, which remain insufficiently described and often overlooked in conservation planning, despite their ecological significance.

The discovery also contributes fundamentally to ichthyology by exemplifying how miniaturized vertebrates negotiate constraints imposed by limited body size. These fishes exhibit adaptations in skeletal morphology, sensory systems, and reproductive strategies that infer evolutionary trade-offs and developmental constraints relevant to vertebrate biology at large. As such, Brachygobius jennie represents a valuable model organism for future studies aiming to unravel these complex biological phenomena.

This finding challenges the assumption that the fish fauna of the Zhujiang River Estuary is exhaustively cataloged. Instead, it reveals that even in relatively well-studied geographic regions, cryptic biodiversity continues to exist, underscoring the infinite complexity and richness of aquatic life. It advocates for continuous exploration and integrative taxonomic research employing advanced tools like molecular genetics to unmask hidden species diversity.

Moreover, the use of integrated genetic and morphological approaches exemplifies modern taxonomic standards, enhancing the accuracy and robustness of species identification. This comprehensive methodology is essential for avoiding taxonomic ambiguities and misidentifications, which can have far-reaching implications for biodiversity assessment, ecological research, and conservation strategies focused on protecting vulnerable taxa and their habitats.

Brachygobius jennie’s diminutiveness invites biologists to probe evolutionary scenarios of size reduction among fishes, including mechanisms such as heterochrony, paedomorphosis, and resource-driven selective pressures. Examining how these tiny organisms maintain viability and reproductive success could uncover key insights into vertebrate life history evolution, with potential applications extending beyond ichthyology into broader evolutionary and developmental biology fields.

In conclusion, the discovery of Brachygobius jennie advances the scientific community’s understanding of fish diversity, biogeography, and evolutionary biology. It also emphasizes the enduring value of meticulous fieldwork, integrative taxonomy, and interdisciplinary collaboration for uncovering the hidden facets of biodiversity. As environmental threats loom over estuarine ecosystems globally, such findings highlight the urgency of documenting and conserving even the smallest and least conspicuous of species, which may hold profound biological and ecological importance.

---

Subject of Research: Animals

Article Title: Brachygobius jennie, a new bumblebee goby (Teleostei, Oxudercidae) from Hengqin Island, Guangdong Province, China

News Publication Date: 17-Jun-2026

Web References:
http://dx.doi.org/10.3897/zse.102.184142

Image Credits: Jiangyan Tian et al. (2026)

Keywords: Brachygobius jennie, Bumblebee goby, New species, Extreme miniaturization, Estuarine fish, Molecular phylogenetics, Morphology, Guangdong Province, Hengqin Island, Ichthyology, Biodiversity, Mangrove wetlands

Paramount Skydance is accusing Netflix of maintaining a campaign against its proposed acquisition of Warner Bros. Discovery (WBD).

In a June 5 letter (PDF) addressed to Jared A. Hughes, acting section chief of the Media, Entertainment, and Communications Section of the US Department of Justice's (DOJ's) Antitrust Division, and A. Maya Kahn, a trial attorney for the Antitrust Division, and first reported on by Politico today, Paramount chief legal officer Makan Delrahim accused Netflix of trying to influence stakeholders about the merger. The letter reads:

Indeed, Netflix’s panic-level response and scorched-earth campaign to try and poison regulators and other stakeholders against the Transaction shows just how seriously Netflix takes Paramount as a scaled competitor.

The letter from Delrahim, a former assistant attorney general for the Antitrust Division, is a response to a letter that The International Brotherhood of Teamsters sent to the DOJ in March. The teamsters' letter argued that Paramount and WBD's merger would threaten film and TV workers. The union, which has 1.3 million members, asked the DOJ to block the merger "unless substantial and enforceable safeguards are put in place to increase domestic production and protect jobs," per an announcement from the group.

Read full article

Comments

© Mike Cohen/Getty Images for The New York Times

While searching for new Higgs bosons the CMS experiment at the Large Hadron Collider (LHC) may have just found a surprise. They have observed an excess of events that look to be a new particle, and are reporting high statistical evidence for their claim. The only question is what exactly is this new particle?

The search was initially designed to look for new, heavier, versions of the Higgs boson decaying to a top quark and an anti-top quark. Its well known that the Higgs boson of the Standard Model, discovered jointly by ATLAS and CMS in 2012, underlies the mechanism which gives all fundamental particles their masses. The Higgs boson itself interacts with particles in proportion to their mass, preferring heavier particles over lighter ones. It therefore interacts the most strongly with the heaviest known fundamental particle, the top quark, which has a mass of ~173 GeV. The Higgs boson itself only has a bass of 125 GeV, meaning conservation of energy dictates it can’t decay into a top quark-antiquark pair.

However many theories of physics beyond the the Standard Model predict additional Higgs bosons, heavier cousins of the current one. If these new heavy Higgs bosons had a mass larger than 350 GeV, they would likely decay to a top quark-antiquark pair quite often. CMS therefore was analyzed its data searching for this signature, hoping to find signs of a new Higgs boson. To do so, they had scrutinize very carefully the known production of top quark-antiquark pairs, which are produced copiously at the LHC from other processes. If a new particle was being produced and decaying to top quarks, the mass of the new particle would give the top quarks a characteristic energy. One key sign of a new particle would therefore be an excess of top quark-antiquark events at a particular energy, corresponding to the mass of the new particle. 

When CMS scrutinized their data looking for such an excess they found one. But curiously right ~350 GeV, the minimum energy required to produce the top quark-antiquark pair. It would be quite the coincidence for a new particle to show up right at this minimum threshold, which made CMS consider alternative possibilities.

 

 One unorthodox explanation that seems to fit the bill is ‘toponium’, a short lived bound state of the top quark-antiquark pair is being formed. Toponium would be the heaviest version of ‘quarkonia’ we have seen, bound states of quark antiquark pairs that form bound states similar to atoms. We have observed and measured quarkonia states of the other quarks for decades, however it was long thought that the top quark, whose large mass causes it to decay in just 10^(-25) seconds, would decay too quickly to create observable bound state effects at a hadron collider. Toponium production would happen most often if the top quarks were produced just at the energy threshold, such that they don’t any extra energy. These low energy top quarks would spend more time close to each other than normal, rather than immediately flying away, so they could have time to briefly form a toponium state before decaying. However, once small hints of intriguing excesses started appearing in LHC analyses, updated calculations in the last few years suggested that perhaps such an effect could be observable.

These calculations are approximate, and more work is still being done to refine them. But the preliminary predictions they give for the properties of toponium seem to match well with what CMS is seeing, both in terms of the rate of toponium production and the quantum properties of the toponium state (spin and parity).

Still CMS is being cautious before claiming a discovery of toponium. They claim observation of an ‘excess at the top quark pair production threshold’ which is consistent with toponium. However given the limited present data and incomplete theoretical models of toponium, they cannot rule out that the excess they are seeing is coming from a new Higgs-like particle.

Further work will be needed to develop improved theoretical models of toponium, and detailed studies from CMS assessing the properties of their observed excess. The excess will also need confirmation from CMS’s rival LHC experiment, ATLAS, to ensure it has not merely made a mistake in its analysis.

However, the smart money would say this very likely looks like toponium. Which, while not signaling the long sought overthrow of the standard model, would be an unexpected and cool surprise from the LHC. Understanding the properties of this previously-thought-impossible quasiparticle will spawn much fruitful research in the years to come. Physicists love a surprise!

Paper:

“Observation of a pseudoscalar excess at the top quark pair production threshold” https://arxiv.org/abs/2503.22382

Additional CMS Paper considering Heavy-Higgs interpretation “Search for heavy pseudoscalar and scalar bosons decaying to top quark pairs in proton-proton collisions”

Read more

CERN Courier “CMS observes top–antitop excess“

Symmetry Magazine “Don’t call it toponium“

Discloure: The author is a member of the CMS collaboration but did not directly work on this analysis

Erratum 4/15/2025 : The article was updated to clarify that in the theory literature prior to the LHC toponium was thought possible to form, just that it was thought to be too small an effect to be observable. The article previously incorrectly stated it had been previously thought impossible to form